Abiopharma

🔍 LIN CHUANG I (Director)

Company: RBB Bancorp (RBB)

Report Date: 2026-05-07

Detailed Transactions and Holdings:

• Acquired 10,000 shares of Common Stock, No Par Value at $18.25 per share (Direct)
  Date: 2026-05-07 | Code: M | equity_swap_involved: 0 | shares_owned_after: 61,347.00 | transaction_form_type: 4
• Sold 10,000 shares of Common Stock, No Par Value at $24.2346 per share (Direct)
  Date: 2026-05-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 51,347.00 | transaction_form_type: 4
• Sold 10,000 shares of Option (right to buy) at $18.25 per share (Derivative)
  Date: 2026-05-07 | Code: M | Expires: 2026-05-17 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1
• Holds 700 shares of Restricted Stock Units (Derivative)
  Date: 2026-05-07 | Code: H | shares_owned_after: 700.00 | Footnotes: F3, F2

Footnotes:

• F1: These options vested in three equal annual installments beginning one year after the 05/17/2016 date of grant.
• F2: There will be no expiration date once restricted stock units vest.
• F3: These remaining restricted stock units vest on 05/21/2026.
• REMARKS: To report a cashless exercise of 10,000 options and the sale of the issued shares.